Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Sep;12(3):602–605. doi: 10.1128/iai.12.3.602-605.1975

Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus.

K R Berquist, J M Peterson, B L Murphy, J W Ebert, J E Maynard, R H Purcell
PMCID: PMC415329  PMID: 1100525

Abstract

We report the temporal patterns of various immunohistological and serological parameters of acute self-limited hepatitis B virus infection of two chimpanzees, and we provide evidence that the synthesis of hepatitis B core antigen precedes that of hepatitis B surface antigen. Our data suggest that existence of a biphasic hepatitis B virus infection involving a hematogenous reinfection of the liver and indicate that recruitment of liver cells to produce hepatitis B virus may occur in a pattern consistent with a replicative cycle of about 8 days.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON A. C., BLUMBERG B. S. An isoprecipitation reaction distinguishing human serum-protein types. Lancet. 1961 Mar 25;1(7178):634–637. doi: 10.1016/s0140-6736(61)91654-3. [DOI] [PubMed] [Google Scholar]
  2. Akeyama T., Kamada T., Koyama M., Abe H. Distribution patterns of hepatitis B antigen in the liver. Immunofluorescence studies. Arch Pathol. 1974 Oct;98(4):252–256. [PubMed] [Google Scholar]
  3. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  4. Barker L. F., Chisari F. V., McGrath P. P., Dalgard D. W., Kirschstein R. L., Almeida J. D., Edington T. S., Sharp D. G., Peterson M. R. Transmission of type B viral hepatitis to chimpanzees. J Infect Dis. 1973 Jun;127(6):648–662. doi: 10.1093/infdis/127.6.648. [DOI] [PubMed] [Google Scholar]
  5. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  6. Blumberg B. S., Sutnick A. I., London W. T. Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med. 1968 Dec;44(12):1566–1586. [PMC free article] [PubMed] [Google Scholar]
  7. Bradley D. W., Maynard J. E., Berquist K. R., Krushak D. H. Hepatitis B and serum DNA polymerase activities in chimpanzees. Nature. 1974 Sep 27;251(5473):356–357. doi: 10.1038/251356a0. [DOI] [PubMed] [Google Scholar]
  8. CLARK H. F., SHEPARD C. C. A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. Virology. 1963 Aug;20:642–644. doi: 10.1016/0042-6822(63)90292-7. [DOI] [PubMed] [Google Scholar]
  9. Edgington T. S., Ritt D. J. Intrahepatic expression of serum hepatitis virus-associated antigens. J Exp Med. 1971 Oct 1;134(4):871–885. doi: 10.1084/jem.134.4.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Irwin G. R., Jr, Hierholzer W. J., Jr, Cimis R., McCollum R. W. Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor. J Infect Dis. 1974 Dec;130(6):580–587. doi: 10.1093/infdis/130.6.580. [DOI] [PubMed] [Google Scholar]
  11. Krugman S., Giles J. P., Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA. 1967 May 1;200(5):365–373. doi: 10.1001/jama.200.5.365. [DOI] [PubMed] [Google Scholar]
  12. Krugman S., Hoofnagle J. H., Gerety R. J., Kaplan P. M., Gerin J. L. Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med. 1974 Jun 13;290(24):1331–1335. doi: 10.1056/NEJM197406132902401. [DOI] [PubMed] [Google Scholar]
  13. Lander H. J., Holland P. V., Alter H. J., Chanock R. M., Purcell R. H. Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. JAMA. 1972 May 22;220(8):1079–1082. doi: 10.1001/jama.220.8.1079. [DOI] [PubMed] [Google Scholar]
  14. Maynard J. E., Berquist K. R., Krushak D. H., Purcell R. H. Experimental infection of chimpanzees with the virus of hepatitis B. Nature. 1972 Jun 30;237(5357):514–515. doi: 10.1038/237514a0. [DOI] [PubMed] [Google Scholar]
  15. Millman I., Zavatone V., Gerstley B. J., Blumberg B. S. Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technic. Nature. 1969 Apr 12;222(5189):181–184. doi: 10.1038/222181b0. [DOI] [PubMed] [Google Scholar]
  16. Nowoslawski A., Brzosko W. J., Madaliński K., Krawczyński K. Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet. 1970 Mar 7;1(7645):494–498. doi: 10.1016/s0140-6736(70)91580-1. [DOI] [PubMed] [Google Scholar]
  17. Purcell R. H., Walsh J. H., Holland P. V., Morrow A. G., Wood S., Chanock R. M. Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis. 1971 Apr;123(4):406–413. doi: 10.1093/infdis/123.4.406. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES